Plasma concentrations of atovaquone given to immunocompromised patients to prevent Pneumocystis jirovecii
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Antimicrobial Chemotherapy"
DOI: 10.1093/jac/dkx198
Abstract: Objectives: Atovaquone is one of the alternatives to trimethoprim/sulfamethoxazole for prophylaxis of Pneumocystis jirovecii pneumonia (PCP) in immunocompromised patients. In volunteers, there was wide inter‐individual variability in atovaquone bioavailability. The aim of this study was… read more here.
Keywords: pneumocystis jirovecii; plasma concentrations; concentrations atovaquone; immunocompromised patients ... See more keywords